Component
Human Caco-2 tight-junction assembly after butyrate
Context-specific entity; species, compartment and exposure are stated on each claim.
3 recorded relationships. Experimental role, claim status and evidence remain attached to each record.
How nutrients influence it
Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.
Other things that act on it
Enzymes, hormones, genes, and other components with a recorded effect. These are not nutrients, so they do not count toward the arrows above. Each finding names the chapter that recorded it.
How nutrients reach it in more than one step
Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.
Tracing routes…
What it does
Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.
What acts on it
Butyrate increased AMPK activity and accelerated tight-junction assembly in human Caco-2 monolayers; compound C abolished the improvement in electrical resistance.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Human Caco-2 monolayers; calcium-switch and permeability assays.
- limitations
- Compound C is not uniquely specific for AMPK; this is a culture mechanism, not proven treatment of human intestinal permeability.
- nutrient_topic
- Butyrate collection; molecular form, preparation, species, exposure and manipulation remain explicit. · Butyrate
- plain_language
- An energy-sensing pathway contributed to barrier assembly.
- primary_references
- Butyrate enhances the intestinal barrier by facilitating tight junction assembly via activation of AMP-activated protein kinase in Caco-2 cell monolayers. · 2009 · https://pubmed.ncbi.nlm.nih.gov/19625695/ · DOI 10.3945/jn.109.104638
Butyrate: microbial production, fuel use, signaling and nutrient interactions (2026-09-19) · lines 262–268
AI-assisted research curation; primary-abstract references and experimental limitations individually identified. Not publisher full text. · supports · Human Caco-2 monolayers; calcium-switch and permeability assays. · source_derived_draft · unverified_draft
## butyrate-tight-junction-ampk An energy-sensing pathway contributed to barrier assembly. Butyrate increased AMPK activity and accelerated tight-junction assembly in human Caco-2 monolayers; compound C abolished the improvement in electrical resistance. Model: Human Caco-2 monolayers; calcium-switch and permeability assays. Limitations: Compound C is not uniquely specific for AMPK; this is a culture mechanism, not proven treatment of human intestinal permeability. Evidence access: Primary abstract Butyrate enhances the intestinal barrier by facilitating tight junction assembly via activation of AMP-activated protein kinase in Caco-2 cell monolayers. · 2009 · https://pubmed.ncbi.nlm.nih.gov/19625695/ · DOI 10.3945/jn.109.104638
Complete structured claim and evidence
Where it participates (unsigned role)
Sodium butyrate reduced MLC2 Ser19 phosphorylation during Caco-2 tight-junction reassembly.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Human Caco-2 phosphorylation measurements.
- limitations
- MLC2 assay identity is retained without guessing the gene isoform from its shorthand name.
- nutrient_topic
- Butyrate collection; molecular form, preparation, species, exposure and manipulation remain explicit. · Butyrate
- plain_language
- The contractile machinery at the cell boundary changed as junctions reformed.
- primary_references
- Sodium Butyrate Promotes Reassembly of Tight Junctions in Caco-2 Monolayers Involving Inhibition of MLCK/MLC2 Pathway and Phosphorylation of PKCβ2. · 2016 · https://pubmed.ncbi.nlm.nih.gov/27735862/ · DOI 10.3390/ijms17101696
Butyrate: microbial production, fuel use, signaling and nutrient interactions (2026-09-19) · lines 286–292
AI-assisted research curation; primary-abstract references and experimental limitations individually identified. Not publisher full text. · supports · Human Caco-2 phosphorylation measurements. · source_derived_draft · unverified_draft
## butyrate-mlc2-junction The contractile machinery at the cell boundary changed as junctions reformed. Sodium butyrate reduced MLC2 Ser19 phosphorylation during Caco-2 tight-junction reassembly. Model: Human Caco-2 phosphorylation measurements. Limitations: MLC2 assay identity is retained without guessing the gene isoform from its shorthand name. Evidence access: Primary abstract Sodium Butyrate Promotes Reassembly of Tight Junctions in Caco-2 Monolayers Involving Inhibition of MLCK/MLC2 Pathway and Phosphorylation of PKCβ2. · 2016 · https://pubmed.ncbi.nlm.nih.gov/27735862/ · DOI 10.3390/ijms17101696
Complete structured claim and evidenceSodium butyrate increased PKC-beta2 Ser660 phosphorylation; PKC-beta inhibition blocked the promoted junction reassembly.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Human Caco-2 signaling and inhibitor experiments.
- limitations
- Inhibitor sensitivity does not imply direct binding of butyrate to PKC-beta2.
- nutrient_topic
- Butyrate collection; molecular form, preparation, species, exposure and manipulation remain explicit. · Butyrate
- plain_language
- A downstream kinase contributed to rebuilding the junction.
- primary_references
- Sodium Butyrate Promotes Reassembly of Tight Junctions in Caco-2 Monolayers Involving Inhibition of MLCK/MLC2 Pathway and Phosphorylation of PKCβ2. · 2016 · https://pubmed.ncbi.nlm.nih.gov/27735862/ · DOI 10.3390/ijms17101696
Butyrate: microbial production, fuel use, signaling and nutrient interactions (2026-09-19) · lines 278–284
AI-assisted research curation; primary-abstract references and experimental limitations individually identified. Not publisher full text. · supports · Human Caco-2 signaling and inhibitor experiments. · source_derived_draft · unverified_draft
## butyrate-pkcb-junction A downstream kinase contributed to rebuilding the junction. Sodium butyrate increased PKC-beta2 Ser660 phosphorylation; PKC-beta inhibition blocked the promoted junction reassembly. Model: Human Caco-2 signaling and inhibitor experiments. Limitations: Inhibitor sensitivity does not imply direct binding of butyrate to PKC-beta2. Evidence access: Primary abstract Sodium Butyrate Promotes Reassembly of Tight Junctions in Caco-2 Monolayers Involving Inhibition of MLCK/MLC2 Pathway and Phosphorylation of PKCβ2. · 2016 · https://pubmed.ncbi.nlm.nih.gov/27735862/ · DOI 10.3390/ijms17101696
Complete structured claim and evidence
The events it takes part in
A mechanism often involves more than two components. These are the full events, with every participant and its role.
Situations it appears in
Low-supply and faulty-machinery situations recorded in the chapters where this component plays a part.
In the sources
Preserved passages that mention this component, quoted exactly. Open one to read it in context.
Open hypotheses
Proposed ideas that involve this component. They are labeled as hypotheses and do not change any recorded statement.
This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.